RVNC   $3.65  0.27% Market Closed

Revance Therapeutics, Inc.

EMA (20): 2025-01-17 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2024-11-08 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2024-11-08 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

Trend Type linear down
Power almost flat
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield -0.54%
EMA (20) date of signal Jan. 17, 2025, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -1.48%
EMA (50) date of signal Nov. 8, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -1.48%
EMA (100) date of signal Nov. 8, 2024, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 0.0
RSI (14) date of signal Feb. 5, 2025, 3 a.m.
MACD Signals bullish weakening
MACD Yield 0.27%
MACD date of signal Feb. 4, 2025, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.0
Stochastic date of signal Feb. 5, 2025, 3 a.m.
Updated Feb. 7, 2025, 11:15 p.m.